Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis
Jeong J, Iwakiri Y. Lymphatic Dysfunction as a Novel Therapeutic Target in Nonalcoholic Steatohepatitis. Cellular And Molecular Gastroenterology And Hepatology 2020, 11: 663-664. PMID: 33220266, PMCID: PMC7846486, DOI: 10.1016/j.jcmgh.2020.10.013.Commentaries, Editorials and LettersHumansNon-alcoholic Fatty Liver Disease